We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Comments on Blister Packs for Immediate-Release Opioids
FDA Seeks Comments on Blister Packs for Immediate-Release Opioids
The FDA is calling for comments on a potential change to the agency’s REMS for opioid pain meds to require blister packaging for certain immediate-release products.